Craig Shimasaki
Craig Shimasaki
President and CEO

Dr. Shimasaki has over 30 years of practical experience in the biotechnology industry and as a serial entrepreneur and cofounder of three biotech companies.  Within these companies he has held a variety of positions, including CEO, Chief Operating Officer, VP of Operations, Executive VP of Research and Director of Project Planning. He has raised multiple rounds of capital, both private and public and has been involved in most every facet of a biotech start-up.

He is intimately familiar with the scientific and technical challenges of product development, and he has led international clinical testing and regulatory approval processes for multiple products through the FDA. He has raised multiple rounds of capital for these companies, and directed the marketing strategy and launch of several products developed for molecular testing and personalized medicine.

He is an inventor of numerous patents for both diagnostic and therapeutic applications. His passion is for the establishment and growth of biotechnology companies focused on developing life-saving products that significantly impact the health and well being of others.

Dr. Shimasaki has served, or presently serves, on the boards of i2E (Innovation to Enterprise) a non-profit technology commercialization center focused on assisting the entrepreneur in taking their ideas through to commercialization; OKBio, the state biotechnology industry organization; the Governor’s Science and Technology Council; the Oklahoma Venture Forum (OVF), a non-profit, venture finance and entrepreneur organization that provides a forum for entrepreneurs to meet potential investors.

He received his B.S. in Biochemistry from the University of California at Davis and his Ph.D. in Molecular Biology and Biotechnology from the University of Tulsa and his M.B.A. from Northwestern University’s Kellogg School of Business.